| scholarly article | Q13442814 |
| P50 | author | Na Liu | Q90451154 |
| P2093 | author name string | Min Tao | |
| Shougang Zhuang | |||
| Yingfeng Shi | |||
| Weijie Yuan | |||
| Jinfang Bao | |||
| P2860 | cites work | Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway | Q24302117 |
| Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction | Q24303900 | ||
| Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases | Q24537111 | ||
| Effect of allopurinol in chronic kidney disease progression and cardiovascular risk | Q24630327 | ||
| Autophagy in Chronic Kidney Diseases | Q26740427 | ||
| Wnt/β-catenin signaling and kidney fibrosis | Q26796624 | ||
| TGF-β signaling via TAK1 pathway: role in kidney fibrosis | Q26824337 | ||
| Uric acid and chronic kidney disease: which is chasing which? | Q26824554 | ||
| Autophagy fights disease through cellular self-digestion | Q27860902 | ||
| Modulation of inflammation by autophagy: Consequences for human disease | Q28082840 | ||
| Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury | Q28579843 | ||
| Methods in mammalian autophagy research | Q29547276 | ||
| Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy | Q33645471 | ||
| Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats | Q33779697 | ||
| Inflammasome-independent modulation of cytokine response by autophagy in human cells | Q33872210 | ||
| Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells | Q34033449 | ||
| Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies | Q34042891 | ||
| Molecular basis of renal fibrosis | Q34125332 | ||
| Lipocalin 2 is essential for chronic kidney disease progression in mice and humans | Q34245315 | ||
| Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling | Q34559028 | ||
| ROS, mitochondria and the regulation of autophagy | Q34679713 | ||
| Suramin inhibits renal fibrosis in chronic kidney disease. | Q35012404 | ||
| Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function | Q35189006 | ||
| Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. | Q35917468 | ||
| EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy | Q36223297 | ||
| Serum Uric Acid and Risk of CKD in Type 2 Diabetes | Q36250295 | ||
| Uric acid as a target of therapy in CKD. | Q36476464 | ||
| Oxidative stress and autophagy: crucial modulators of kidney injury | Q36717785 | ||
| Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury | Q36986519 | ||
| Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction | Q37041558 | ||
| Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis | Q37164546 | ||
| TGF-beta signal transduction in chronic kidney disease | Q37410310 | ||
| New autophagy reporter mice reveal dynamics of proximal tubular autophagy | Q37524096 | ||
| Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury | Q37591248 | ||
| Tubule-Derived Wnts Are Required for Fibroblast Activation and Kidney Fibrosis. | Q51088935 | ||
| Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association. | Q53128563 | ||
| The role of autophagy in unilateral ureteral obstruction rat model. | Q53398591 | ||
| Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated l | Q59321551 | ||
| TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen | Q79771332 | ||
| Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and α-smooth muscle actin | Q37729850 | ||
| Autophagy regulates Notch degradation and modulates stem cell development and neurogenesis. | Q38266043 | ||
| Notch in fibrosis and as a target of anti-fibrotic therapy | Q38815773 | ||
| Time to target uric acid to retard CKD progression | Q38848997 | ||
| Autophagy and Tubular Cell Death in the Kidney. | Q38875284 | ||
| Tgf-β1 induces autophagy and promotes apoptosis in renal tubular epithelial cells | Q39398769 | ||
| Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells | Q39977465 | ||
| Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial | Q41522596 | ||
| The role of hyperuricemia on vascular endothelium dysfunction | Q41530508 | ||
| TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling | Q41592988 | ||
| Inhibition of Notch Signaling Promotes the Adipogenic Differentiation of Mesenchymal Stem Cells Through Autophagy Activation and PTEN-PI3K/AKT/mTOR Pathway | Q41917164 | ||
| DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy | Q42288800 | ||
| Uric acid, CKD, and cardiovascular disease: confounders, culprits, and circles | Q42551663 | ||
| RETRACTED: Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms | Q42563749 | ||
| Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes | Q42804909 | ||
| Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. | Q44438488 | ||
| Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease | Q44855203 | ||
| Autophagy protects renal tubular cells against cyclosporine toxicity | Q45069349 | ||
| The Notch pathway in podocytes plays a role in the development of glomerular disease | Q46725170 | ||
| Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level | Q46867932 | ||
| Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation. | Q47107722 | ||
| iASPP facilitates tumor growth by promoting mTOR-dependent autophagy in human non-small-cell lung cancer | Q47151471 | ||
| From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases. | Q47604057 | ||
| Mitophagy regulates macrophage phenotype in diabetic nephropathy rats | Q47615011 | ||
| Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease | Q47734980 | ||
| Impact of Uric Acid Levels on Kidney Disease Progression. | Q47739334 | ||
| High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway. | Q47826501 | ||
| Increased autophagy contributes to the inflammatory phenotype of juvenile idiopathic arthritis synovial fluid T cells. | Q47907119 | ||
| Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy | Q47934028 | ||
| The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies | Q49793137 | ||
| Management Strategies for Patients with Diabetic Kidney Disease and Chronic Kidney Disease in Diabetes | Q50101193 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| autophagy | Q288322 | ||
| kidney disease | Q1054718 | ||
| P304 | page(s) | 2299-2322 | |
| P577 | publication date | 2018-11-02 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy | |
| P478 | volume | 132 |
| Q96576448 | Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy |
| Q97517003 | Dexmedetomidine Enhances Autophagy via α2-AR/AMPK/mTOR Pathway to Inhibit the Activation of NLRP3 Inflammasome and Subsequently Alleviates Lipopolysaccharide-Induced Acute Kidney Injury |
| Q64099793 | FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose |
| Q92860079 | Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy |
| Q92408391 | NPS2390, a Selective Calcium-sensing Receptor Antagonist Controls the Phenotypic Modulation of Hypoxic Human Pulmonary Arterial Smooth Muscle Cells by Regulating Autophagy |
| Q64074971 | Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional study |
Search more.